Talphera, Inc. (NASDAQ:TLPH – Get Free Report) shares rose 1.9% during trading on Thursday . The stock traded as high as $1.10 and last traded at $1.07. 426,577 shares were traded during trading, an increase of 66% from the average daily volume of 257,145 shares. The stock had previously closed at $1.05.
Analyst Upgrades and Downgrades
A number of research firms have weighed in on TLPH. HC Wainwright began coverage on Talphera in a research report on Friday, June 5th. They set a “buy” rating and a $3.00 price objective for the company. Westpark Capital started coverage on shares of Talphera in a research note on Thursday, April 30th. They set a “buy” rating and a $3.00 price target on the stock. Zacks Research upgraded shares of Talphera to a “hold” rating in a report on Monday, June 8th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Talphera in a research note on Monday, April 20th. Two research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Talphera has a consensus rating of “Hold” and an average target price of $3.00.
Read Our Latest Report on TLPH
Talphera Price Performance
Talphera (NASDAQ:TLPH – Get Free Report) last issued its quarterly earnings data on Wednesday, May 13th. The company reported ($0.04) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.03. On average, analysts predict that Talphera, Inc. will post -0.26 earnings per share for the current year.
Hedge Funds Weigh In On Talphera
A number of institutional investors have recently made changes to their positions in TLPH. AIGH Capital Management LLC lifted its position in shares of Talphera by 4.6% in the fourth quarter. AIGH Capital Management LLC now owns 4,661,502 shares of the company’s stock valued at $5,314,000 after acquiring an additional 206,957 shares in the last quarter. Rosalind Advisors Inc. increased its position in Talphera by 118.9% during the 3rd quarter. Rosalind Advisors Inc. now owns 4,385,757 shares of the company’s stock worth $3,917,000 after purchasing an additional 2,381,818 shares in the last quarter. Nantahala Capital Management LLC raised its stake in Talphera by 75.3% in the 3rd quarter. Nantahala Capital Management LLC now owns 3,492,519 shares of the company’s stock valued at $3,120,000 after purchasing an additional 1,500,000 shares during the last quarter. Empery Asset Management LP acquired a new position in Talphera in the 4th quarter valued at about $1,520,000. Finally, Cantor Fitzgerald L. P. purchased a new position in Talphera in the 4th quarter valued at about $658,000. 37.67% of the stock is owned by institutional investors and hedge funds.
Talphera Company Profile
Talphera, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe.
Featured Articles
- Five stocks we like better than Talphera
- D.R. Horton Is Defying the Housing Gloom
- Why Flywire and Airbnb Could Be Quiet Winners of a Ceasefire
- Broadcom and OpenAI Unveil Jalapeño: An Early Step to Massive AI Growth Potential
- MarketBeat Week in Review – 06/29 – 07/03
Receive News & Ratings for Talphera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Talphera and related companies with MarketBeat.com's FREE daily email newsletter.
